Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Multicenter Trial

NCT00815763 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT00815763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00815763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Multicenter Trial
Lead sponsor
Xijing Hospital
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
September 30, 2008
Enrollment
390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke